Predictors and trends of contrast use and radiation exposure in a large cohort of patients treated with percutaneous coronary interventions: Chronic total occlusion analysis based on a national registry

BACKGROUND The aim herein, was to assess predictors and current trends of radiation exposure and total contrast amount use in patients treated with percutaneous coronary intervention within chronic total occlusion (CTO PCI) and non-CTO PCI. METHODS Based on a nationwide registry (ORPKI), 535,857 patients treated with PCI between 2014 and 2018 were analysed. The study included 12,572 (2.34%) patients treated with CTO PCI. The CTO PCI and non-CTO PCI groups were compared before and after propensity score matching (PSM). Multifactorial mixed regression models were used to assess predictors of contrast amount use and radiation exposure. RESULTS The mean total contrast dose and radiation exposure decrease reached statistical significance in following years for the CTO PCI (p = 0.002 and p < 0.001) and non-CTO PCI groups (p < 0.001 and p < 0.001). Multifactorial analysis revealed that non-CTO PCI was a strong independent predictor of lower total contrast dose (estimate: -17.41; 95% confidence interval [CI]: -18.45 to -16.49, p < 0.001) and radiation exposure (estimate: -264.28; 95% CI: -273.75 to -254.81, p < 0.001). After PSM, it was confirmed that CTO PCI was an independent predictor of greater radiation exposure (estimate: 328.6; 95% CI: 289.1-368.1; p < 0.001) and total contrast dose (estimate: 30.5; 95% CI: 27.28-33.74; p < 0.001). CONCLUSIONS Contrast dose and radiation exposure have decreased in previous years with regard to the CTO PCI and non-CTO PCI groups. CTO PCI was found to be an independent predictor of greater total contrast dose and radiation exposure in the overall group of patients treated with PCI.

[1]  G. Werner,et al.  Reducing fluoroscopic and cineangiographic contribution to radiation exposure for chronic total coronary occlusion interventions. , 2021, Cardiovascular revascularization medicine : including molecular interventions.

[2]  M. Meah,et al.  Complex Chronic Total Occlusion Revascularization - A Comparison of Biradial Versus Femoral Access. , 2021, The Journal of invasive cardiology.

[3]  G. Werner,et al.  Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  K. Alaswad,et al.  Zero-iodinated contrast retrograde percutaneous coronary interventions of chronic total occlusions using gadolinium and imaging guidance: a case report of a patient with severe anaphylaxis to iodinated contrast , 2020, European heart journal. Case reports.

[5]  S. Garcia,et al.  Temporal Trends in Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO Registry. , 2020, The Journal of invasive cardiology.

[6]  S. Garcia,et al.  Use of the DyeVert System in Chronic Total Occlusion Percutaneous Coronary Intervention. , 2019, The Journal of invasive cardiology.

[7]  C. Di Mario,et al.  Temporal Trends in Chronic Total Occlusion Interventions in Europe: 17 626 Procedures From the European Registry of Chronic Total Occlusion , 2018, Circulation. Cardiovascular interventions.

[8]  Z. Siudak,et al.  Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions , 2018, PloS one.

[9]  Z. Siudak,et al.  Predictors of in‐hospital effectiveness and complications of rotational atherectomy (from the ORPKI Polish National Registry 2014–2016) , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  C. Di Mario,et al.  A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions , 2018, European heart journal.

[11]  E. Kretov,et al.  The IMPACTOR-CTO Trial. , 2018, JACC. Cardiovascular interventions.

[12]  Yuji Hamazaki,et al.  Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusion Performed by Highly Experienced Japanese Specialists: The First Report From the Japanese CTO-PCI Expert Registry. , 2017, JACC. Cardiovascular interventions.

[13]  R. Brindis,et al.  A Contemporary Overview of Percutaneous Coronary Interventions , 2016 .

[14]  Subhash Banerjee,et al.  Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: Insights from a multicenter united states registry , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  J. Spertus,et al.  Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). , 2015, JACC. Cardiovascular interventions.

[16]  Omar M. Jeroudi,et al.  Prevalence and management of coronary chronic total occlusions in a tertiary veterans affairs hospital , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  Ulf J Jensen,et al.  Chronic Total Occlusions in Sweden – A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) , 2014, PloS one.

[18]  Michael E Matheny,et al.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. , 2014, JACC. Cardiovascular interventions.

[19]  Subhash Banerjee,et al.  Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. , 2013, JACC. Cardiovascular interventions.

[20]  G. Wright,et al.  Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. , 2012, Journal of the American College of Cardiology.

[21]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[22]  C. Di Mario,et al.  In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[23]  Stephen Balter,et al.  Radiation safety program for the cardiac catheterization laboratory , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  Volkmar Falk,et al.  Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[25]  Y. Hayashi,et al.  In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). , 2010, JACC. Cardiovascular interventions.

[26]  J. Spertus,et al.  Chronic total occlusion angioplasty in the United States. , 2009, JACC. Cardiovascular interventions.

[27]  R. Christofferson,et al.  Effect of chronic total coronary occlusion on treatment strategy. , 2005, The American journal of cardiology.

[28]  K. Faulkner,et al.  Patient dose values in a dedicated Greek cardiac centre. , 2003, The British journal of radiology.

[29]  S. Hou,et al.  Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.